Biosion, Inc.
Clinical trials sponsored by Biosion, Inc., explained in plain language.
-
New eczema shot tested for safety in first human trial
Disease control CompletedThis was a first-step safety study for a new injectable drug called BSI-045B, intended to treat atopic dermatitis (eczema). Researchers tested single and multiple doses in 54 healthy volunteers and a small group of patients with moderate-to-severe eczema to see how safe and toler…
Phase: PHASE1 • Sponsor: Biosion, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New shot aims to tame severe skin rash
Disease control CompletedThis study tested a new injectable medication called BSI-045B for adults with moderate to severe atopic dermatitis (eczema). Twenty-two participants received injections weekly for a month, then every two weeks for about six months. Researchers measured how much the treatment redu…
Phase: PHASE2 • Sponsor: Biosion, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC